Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
HEPVIR working group of the European Society for translational antiviral research (ESAR)
Research output: Contribution to journal › Article › peer-review
41Scopus
citations
Fingerprint
Dive into the research topics of 'Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe'. Together they form a unique fingerprint.